Back

Evaluation of the utility of inhaled nitric oxide therapy in ECPELLA management

31 August 2026 (13:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Pathophysiological mechanisms in acute cardiac injury Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Motomaro Tanaka

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on innovative therapies for acute cardioprotection
Professor D. Hausenloy (Singapore, SG)
Presentation thumbnail
Evolving ICU strategies and improved survival in cardiogenic shock: a 13-year cohort study
Mrs J. Aydin-Rosu (Munich, DE)
Abstract
Presentation thumbnail
Early postoperative administration of proton pump inhibitors and acute kidney injury after cardiac surgery
Doctor R. An (CN)
Abstract

Access the full session

Session thumbnail
Pathophysiological mechanisms in acute cardiac injury

The Event

Event poster

ESC Congress 2026

31 August 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Association of inhaled nitric oxide with VA-ECMO weaning and short-term outcomes in ECPELLA patients: a retrospective study
29 August 2025
thumbnail
Congress Presentation
Prognostic value of different lactate metrics in patients treated with peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
20 March 2026
thumbnail
Congress Presentation
Effects of inhaled nitric oxide on the pulmonary circulatory system in a porcine model of heart transplantation.
20 March 2026
thumbnail
Congress Presentation
Sodium nitroprusside in heart failure-related and acute myocardial infarction-related cardiogenic shock: friend or foe?
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources